Human hepatocyte growth factor (hHGF)-modified hepatic oval cells improve liver transplant survival.

Despite progress in the field of immunosuppression, acute rejection is still a common postoperative complication following liver transplantation. This study aims to investigate the capacity of the human hepatocyte growth factor (hHGF) in modifying hepatic oval cells (HOCs) administered simultaneousl...

Full description

Bibliographic Details
Main Authors: Zhu Li, Juan Chen, Li Li, Jiang-Hua Ran, Xue-Hua Li, Zhi-Heng Liu, Gui-Jie Liu, Yan-Chao Gao, Xue-Li Zhang, Hiu-Dong Sun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3445612?pdf=render